Moneycontrol
HomeNewsTrendsCurrent AffairsChina starts anal swab tests for people at high risk of contracting COVID-19
Trending Topics

China starts anal swab tests for people at high risk of contracting COVID-19

the anal swabs method “can increase the detection rate of infected people” as traces of the virus linger longer in the anus than in the respiratory tract, Li Tongzeng, a senior doctor from Beijing’s You’an Hospital, has said.

January 27, 2021 / 20:49 IST
Story continues below Advertisement

Source: New York Times

China has begun using anal swabs to test those it considers at high risk of contracting COVID-19, state TV reported, with social media users and travellers squirming over the invasive procedure which doctors say can be more effective in detecting the virus.

Officials took anal swabs from residents of neighbourhoods with confirmed COVID-19 cases in Beijing last week, broadcaster CCTV said, while those in designated quarantine facilities have also undergone the test. For live updates on coronavirus, click here

Small, localised outbreaks in recent weeks have seen multiple cities in northern China sealed off from the rest of the country and prompted mass testing campaigns -- which up until now have mostly been conducted using throat and nose swabs.

Story continues below Advertisement

But the anal swabs method “can increase the detection rate of infected people” as traces of the virus linger longer in the anus than in the respiratory tract, Li Tongzeng, a senior doctor from Beijing’s You’an Hospital, told CCTV.

Users of China’s popular Twitter-like Weibo social media platform reacted to the method with a mix of mirth and horror.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show